Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Sanofi, Merck Group, Qualcomm and Menorah Mivtachim participated in the latest round for the medication management platform developer.

SIG affiliate Heights Capital Management was among the investors in a series B round for the small molecule therapeutics developer.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Funding from investors including Providence Health will allow the musculoskeletal treatment provider to expand its offering and healthcare network.

The Jinlong Group-backed biologic drug developer’s latest round pushed its overall funding from the past 12 months to approximately $387m.

Microsoft unit M12 backed the healthcare data software provider in a round that valued the latter at $1.3bn, pushing its overall funding past $225m.

IDG Capital has led a round, sized at hundreds of millions of yuan, for the 6 Dimensions Capital-backed cancer therapeutics developer.

The Intermountain Healthcare-backed healthcare data software provider's total funding stands at $95m following its series D round.

University of Alberta spinout Tevosol has been picked up by Bridge to Life but will maintain its base in Edmonton.